ES2171556T3 - Procedimiento de preparacion de compuestos de silicio biologicamente activos en forma concentrada. - Google Patents

Procedimiento de preparacion de compuestos de silicio biologicamente activos en forma concentrada.

Info

Publication number
ES2171556T3
ES2171556T3 ES95933458T ES95933458T ES2171556T3 ES 2171556 T3 ES2171556 T3 ES 2171556T3 ES 95933458 T ES95933458 T ES 95933458T ES 95933458 T ES95933458 T ES 95933458T ES 2171556 T3 ES2171556 T3 ES 2171556T3
Authority
ES
Spain
Prior art keywords
links
procedure
preparation
biologically active
active silicon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933458T
Other languages
English (en)
Inventor
Marie-Christine Seguin
Jean Gueyne
Jean-Francois Nicolay
Andre Franco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exsymol SAM
Original Assignee
Exsymol SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exsymol SAM filed Critical Exsymol SAM
Application granted granted Critical
Publication of ES2171556T3 publication Critical patent/ES2171556T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0836—Compounds with one or more Si-OH or Si-O-metal linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences
    • C07F7/0872—Preparation and treatment thereof
    • C07F7/0874—Reactions involving a bond of the Si-O-Si linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Silicon Polymers (AREA)

Abstract

PROCEDIIENTO DE PREPARACION DE UN COMPUESTO A BASE DE SILICIO BIOLOGICAMENTE ACTIVO QUE CONSISTE EN HIDROLIZAR UN PRECURSOR DE FORMULA (I); EN LA QUE A, B, C, D, Y X REPRESENTAN RADICALES DIFERENTES DE OH, SIENDO LOS ENLACES DE A, B, C D CON EL ATOMO SI ENLACES COVALENTES Y 2 O 3 DE ESTOS ENLACES SE PUEDEN HIDROLIZAR. LA HIDROLISIS SE EFECTUA EN UN SOLVENTE QUE CONTIENE UNA PEQUEÑA CANTIDAD DE AGUA EN UNA PROPORCION RESPECTO DEL SOLVENTE COMPRENDIDA PREFERENTEMENTE ENTRE 0,1% Y 5%, Y AL MENOS UNO DE LOS COMPUESTOS PROCEDENTES DE LOS ENLACES HIDROLIZADOS DEL SILICIO ES UN COMPUESTO LLAMADO ESTABILIZANTE QUE IMPIDE LA FORMACION DE POLIMEROS A PARTIR DE LOS ENLACES HIDROLIZADOS DEL SILICIO.
ES95933458T 1994-09-30 1995-09-29 Procedimiento de preparacion de compuestos de silicio biologicamente activos en forma concentrada. Expired - Lifetime ES2171556T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412089A FR2725208B1 (fr) 1994-09-30 1994-09-30 Procede de preparation de composes de silicium biologiquement actifs sous forme concentree

Publications (1)

Publication Number Publication Date
ES2171556T3 true ES2171556T3 (es) 2002-09-16

Family

ID=9467729

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933458T Expired - Lifetime ES2171556T3 (es) 1994-09-30 1995-09-29 Procedimiento de preparacion de compuestos de silicio biologicamente activos en forma concentrada.

Country Status (16)

Country Link
US (1) US6172250B1 (es)
EP (1) EP0737199B1 (es)
JP (1) JP4194116B2 (es)
KR (1) KR100440423B1 (es)
CN (1) CN1136315A (es)
AU (1) AU702457B2 (es)
BR (1) BR9506388A (es)
CA (1) CA2176510C (es)
CZ (1) CZ296427B6 (es)
DE (1) DE69525444T2 (es)
ES (1) ES2171556T3 (es)
FR (1) FR2725208B1 (es)
HU (1) HU226009B1 (es)
MX (1) MX9602028A (es)
PT (1) PT737199E (es)
WO (1) WO1996010574A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761075B1 (fr) * 1997-03-24 1999-06-11 Seguin Marie Christine Nouveaux composes a base de silicium biologiquement actifs et leurs applications therapeutiques
ES2147538B1 (es) * 1999-01-29 2001-04-01 Revlon Consumer Prod Corp Una locion capilar con propiedades mejoradas en su accion protectora del cabello y preventiva de su caida, y de reduccion de los efectos externos de la alopecia androgenetica y con ello de la caida del cabello.
DE69930971T2 (de) 1999-09-27 2007-04-12 L'oreal Kosmetische zusammensetzung auf basis von silicium-organischen verbindungen, die mindestens eine nicht basische solubilisierende funktion aufweisen
WO2001022932A1 (fr) * 1999-09-27 2001-04-05 L'oreal Composition cosmetique a base de composes organiques du silicium comportant au moins une fonction a effet cosmetique
US6953572B1 (en) 1999-09-27 2005-10-11 L'oreal Cosmetic compositions based on partly neutralized organic silicon compounds
EP1583765A4 (en) * 2002-11-18 2008-03-26 Grenpharma Llc COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES CHARACTERIZED BY THE PRESENCE OF METALLIC IONS
WO2004045552A2 (en) * 2002-11-18 2004-06-03 Grenpharma Llc Compositions for treating and/or preventing diseases characterized by the presence of metal ions
US7595308B2 (en) * 2002-11-18 2009-09-29 Grenpharma Llc Compositions for treating and/or preventing diseases characterized by the presence of metal ions
WO2004100926A2 (en) * 2003-05-13 2004-11-25 Medtronic, Inc. Delivery of agents using hydrolyzable leaving groups
CA2586681A1 (en) * 2004-10-22 2006-05-04 Thomas C. Pochapsky Compositions for treating and/or preventing diseases characterized by the presence of the metal ions
RU2281169C1 (ru) 2004-12-06 2006-08-10 Закрытое акционерное общество "Научно-производственный внедренческий центр "Уральский научно-исследовательский и проектный институт обогащения и механической обработки полезных ископаемых - Техника" (ЗАО НПВЦ "Уралмеханобр - Техника") Флотационная колонная пневматическая машина
US8069270B1 (en) 2005-09-06 2011-11-29 Cisco Technology, Inc. Accelerated tape backup restoration
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
WO2016089718A1 (en) * 2014-12-02 2016-06-09 Merck Sharp & Dohme Corp. Process for the preparation of tert-butyl 4-((2s,5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate and analogs thereof
FR3053249B1 (fr) 2016-07-02 2021-07-02 Estelle Piron Formulation cosmetique comprenant au moins une huile, une vitamine c et un silicium
BE1023898B1 (fr) 2016-08-25 2017-09-07 Sil'innov Scrl Composition comprenant du silicium et son procédé de préparation
FR3110573B1 (fr) * 2020-05-20 2024-01-19 Exsymol Sa Compositions comprenant des composés organo-silanols, et applications.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL107064C (es) * 1956-08-04
MC1067A1 (fr) * 1975-07-04 1976-05-21 C Gueyne Un procede de fabrication de silanols solubles dans l'eau biologiquement actifs
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
FR2619113B2 (fr) * 1987-05-26 1991-06-28 Exsymol Sa Nouveaux produits de condensation de silanols, leurs preparation et application
FR2645863B1 (fr) * 1989-04-12 1994-09-23 Voisin Philippe Composes de silicium et procede de fabrication de ceux-ci
US5648511A (en) * 1990-11-19 1997-07-15 G.D. Searle & Co. Method for making intermediates useful in the synthesis of retroviral protease inhibitors
FR2725207B1 (fr) * 1994-09-30 1996-11-29 Exsymol Sa Composes a base de silicium biologiquement actifs, leurs applications therapeutiques et cosmetiques

Also Published As

Publication number Publication date
KR100440423B1 (ko) 2004-10-12
MX9602028A (es) 1998-01-31
EP0737199A1 (fr) 1996-10-16
AU702457B2 (en) 1999-02-25
BR9506388A (pt) 1997-11-18
HU226009B1 (en) 2008-02-28
FR2725208A1 (fr) 1996-04-05
EP0737199B1 (fr) 2002-02-13
CA2176510C (fr) 2007-04-03
JP4194116B2 (ja) 2008-12-10
HU9601251D0 (en) 1996-07-29
DE69525444T2 (de) 2002-10-10
PT737199E (pt) 2002-07-31
CA2176510A1 (fr) 1996-04-11
HUT74604A (en) 1997-01-28
CZ296427B6 (cs) 2006-03-15
US6172250B1 (en) 2001-01-09
JPH09505836A (ja) 1997-06-10
WO1996010574A1 (fr) 1996-04-11
DE69525444D1 (de) 2002-03-21
FR2725208B1 (fr) 1996-11-29
AU3611395A (en) 1996-04-26
CZ145896A3 (en) 1997-02-12
CN1136315A (zh) 1996-11-20

Similar Documents

Publication Publication Date Title
ES2171556T3 (es) Procedimiento de preparacion de compuestos de silicio biologicamente activos en forma concentrada.
DK1177176T3 (da) Triarylsyrederivater som PPAR-receptorligander
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
PT804200E (pt) Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos
HK1013289A1 (en) Naphthalene derivatives as prostaglandin 12 agonists
CO5251404A1 (es) Compuestos antibioticos de azalida
IS1806B (is) Arylthíósambönd sem varnarefni gegn bakteríum og veirum
EP1489128A4 (en) SILICONE MODIFIED BY POLYGLYCEROL BRANCHED
MXPA03001081A (es) Medicamento anti-inflamatorio.
FI912899A0 (fi) Foerfarande foer framstaellning av hexahydroazepinderivat.
ATE241574T1 (de) Kieselsäurehaltiges substrat mit einer silanschicht und dessen herstellung
RS50002B (sr) Eletriptan hidrobromid monohidrat
CO4950614A1 (es) Antagonistas de taquiquinina
ES2162795T3 (es) Inhibicion de la formacion de polimeros en forma de palomitas de maiz con compuestos que contienen azufre.
CS387391A3 (en) Phenylalkylaminoalkyl compounds, process of their preparation andmedicaments comprising said compounds
HUP0300264A2 (hu) Linezolid intravénás oldatot tartalmazó tartály
AR033030A1 (es) Procedimiento para la produccion de peroxido de hidrogeno
CO4980899A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
AR032639A1 (es) Una composicion de tratamiento para lavar, empleo de un polimero presente en dicha composicion, una estructura polimerica y un metodo para fabricar dichos polimeros
NZ514573A (en) Beta-hydroxyalkylamides, process for their production and their use
AR002288A1 (es) Un método para preparar un salicilato de sililo biológicamente activo estabilizado por ácido salicílico, y composiciones cosmeticas y terapéuticas que contienen el salicilato de sililo biológicamente activo estabilizado por ácido salicílico.
DE50201297D1 (de) Verfahren zur herstellung von 1-hydroxy-1, 1-diphosphonsäureverbindungen
BR0209874A (pt) Clorometilação de tiofeno
GB9914085D0 (en) New use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 737199

Country of ref document: ES